International Trade Today is a service of Warren Communications News.
Subscriber Login

EAPA Litigation

Under the Enforce and Protect Act, CBP investigates whether a company is evading particular antidumping and countervailing duty orders. Litigation on determinations made under the relatively new statute have centered on due process protections for respondents, CBP's evidentiary basis for its decisions and the interplay of decisions made on the scope of the applicable AD/CVD orders from both CBP and the Commerce Department. The Court of Appeals for the Federal Circuit issued a key decision for all EAPA cases in Royal Brush Manufacturing v. United States, when it found CBP to have violated a respondent's due process protections by failing to provide it with access to the business proprietary information used in the proceeding. 

to
Refine Category Search
Clear Terms

Search Primer

Multi-word term: Place inside quotes to ensure an exact match together (e.g. "China import").

Term list: Separate terms with spaces, not commas or semicolons to find either word (e.g. AD/CVD antidumping).

Acronyms: Use all capital letters (e.g., ACE).

Required term: If a term must be included in any resulting articles, prefix it with a plus sign (e.g., CBP +releases).

Excluded term: If a term should be excluded from any articles being found, prefix it with a minus sign (e.g., -ruling).

Singular form: Use the singular form when doing multi-word terms (e.g. "russian export control" instead of "russian export controls").

Shortest word form: When you have different word forms in a quoted term, include the shortest version if it is the last part of the expression (e.g., "entity list" instead of "entity listing" or "entity listed").

Yale Professor to Take Over as Director of FDA Food Office
November 12, 2014 |FDA

Susan Mayne will take over in January 2015 as director of the Food and Drug Administration’s Center for Drug Evaluation for Research, said FDA in a constituent update (here). Mayne will replace Michael Landa, who has led the center since 2010. Mayne is currently chair of the Department of Chronic Disease Epidemiology at the Yale School of Public Health.

FDA Restructuring Regional Organization, Says Veneziano
November 7, 2014 |FDA

The Food and Drug Administration is in the process of restructuring "the entire organization," said Domenic Veneziano, director of the FDA Division of Import Operations, during the Nov. 6 Northeast Cargo Symposium. The "refocusing" includes a look at the regional division of the Office of Regulatory Affairs, which handles imports and enforcement policy at the agency, he said at the symposium, a Coalition of New England Companies for Trade event. The hope is to "add uniformity across the country" by having decisions come from one place within the FDA, he said. Currently, the FDA field offices that process imports are divided into five regions.

FDA Finalizes Requirement for DUNS Number in Drug Facility Registrations
November 5, 2014 |FDA

The Food and Drug Administration finalized its guidance that outlines the Unique Facility Identifier (UFI) system for use in registration foreign and domestic drug facilities (here). The guidance specifies that drug establishments should include a Data Universal Numbering System (DUNS) from Dun and Broadstreet as the UFI in their initial registrations and annual registration renewals, although other forms of identifiers are allowed with FDA approval. The final guidance makes few changes from a draft guidance issued in September 2013 (see 13090518). DUNS numbers are already required for drug establishments to register in the electronic Structured Product Labeling format, said an FDA spokesman.

Other Modified FDA Import Alerts for the Week of Oct. 27 - Nov. 2
November 4, 2014 |FDA

During the week of Oct. 27 - Nov. 2, the Food and Drug Administration modified the following existing Import Alerts (not otherwise listed on the FDA's new and revised import alerts page) on the detention without physical examination and/or surveillance of: